Preclinical evaluation of [18F]cabozantinib as a PET imaging agent in a prostate cancer mouse model
2019 ◽
Vol 60
(9)
◽
pp. 1284-1292
◽
Keyword(s):
Keyword(s):
2018 ◽
Vol 318
(3)
◽
pp. 2097-2105
◽
2013 ◽
Vol 41
(1)
◽
pp. 89-101
◽
Keyword(s):
2014 ◽
Vol 41
(6)
◽
pp. 477-487
◽